Touching Base
By Genetic Engineering & Biotechnology News (GEN)
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 1
Reviews: 0
Episodes: 40
Description
Touching Base is the dynamic podcast series from the editors of GEN (Genetic Engineering & Biotechnology News). Each episode features a rotating cast of senior editors including John Sterling, Kevin Davies, Julianna LeMieux, Alex Philippidis, Uduak Thomas, Corinna Singleman and Fay Lin who delve into emerging stories, exchange ideas, and debate the latest trends in biotech. Additionally, they talk to some of the leading voices in the industry about what's now and next.
Hosted on Acast. See acast.com/privacy for more information.
| Episode | Date |
|---|---|
|
Lung Organoids, Autism and Sarcopenia Insights in Mice, and a Bidding War Ends
|
Dec 04, 2025 |
|
New Nasal Vaccines, Korro Stock Dips, J&J and Merck Acquisitions, and Dyno GATC
|
Nov 20, 2025 |
|
uniQure Staggers at FDA, Recursion's Microglia Map, and Leadership Transitions
|
Nov 07, 2025 |
|
Artificial Intelligence in the Emerald City and Targeting Colon Cancer Stem Cells
|
Oct 24, 2025 |
|
Nobel Prizes Announced and Breakthroughs for Huntington’s and Rare Diseases
|
Oct 10, 2025 |
|
BPI 2025 Debrief and Takeaways
|
Sep 26, 2025 |
|
Developing New Therapies Through Partnership, Electricity, and Immunotherapy
|
Sep 05, 2025 |
|
Stem Cells in Space and AI for Nanoparticles and Peptide Design
|
Aug 22, 2025 |
|
Reversing Parkinson’s in Mice, Protecting Primates from HIV, Top 10 Biotech Clusters, and Sarepta
|
Aug 08, 2025 |
|
Sarepta Under Scrutiny, AstraZeneca’s Big Bet, and AI vs. IDRs
|
Jul 25, 2025 |
|
Merck Acquires Verona, Virtual Cell Challenge, Gene Therapy Restores Hearing
|
Jul 11, 2025 |
|
BIO 2025, Huge Virtual Cell Dataset, AI-Designed De Novo Proteins
|
Jun 18, 2025 |
|
Rocket’s Gene Therapy Trial Paused, Boltz-2 Open Source, Plasma Swap Rewinds Aging
|
Jun 06, 2025 |
|
Customized CRISPR for KJ, 10x and Illumina Lawsuits, Regeneron Bags 23andMe
|
May 22, 2025 |
|
Insights into COVID-19’s Origins, Recursion Reverses Course, and AACR Stands Up for Cancer Research
|
May 09, 2025 |
|
Navigating Biotech’s New Normal, Applying AI to Cas9 Enzymes, and Sequencing Generations
|
Apr 25, 2025 |
|
Discussing De-Extinction, Trump’s Tariffs Touch Biopharma, and Reports from Recent Travels
|
Apr 11, 2025 |
|
Dravet Gene Therapy Tested in Mice, Sarepta’s Setback, and AstraZeneca Updates
|
Mar 28, 2025 |
|
Genetic Engineering at Asilomar, Stand Up for Science, and Francis Collins
|
Mar 14, 2025 |
|
AI Models Writing DNA and Designing Enzymes, Some Pre-AGBT News
|
Feb 28, 2025 |
|
Recursion Clinical Trial, CRISPR Delivery methods, preclinical Cas12 use, Gene Editing in AgBio, Top 10 Takeover Targets
|
Feb 14, 2025 |
|
DNA Day: Deep Dive
|
Apr 26, 2024 |
|
How Biotechs Are Plugging AI into Drug Discovery Problems
|
Apr 19, 2024 |
|
Launch of Nvelop Therapeutics for Delivery of Genetic Cargo, AACR Recap
|
Apr 12, 2024 |
|
Dried Blood COVID Dx, Cryo-Shocked Tumor Cell Delivery Vehicles, Verve Halts Trial, Iambic Starts Trial, and Diagonal Therapeutics Launches
|
Apr 05, 2024 |
|
AI in Drug Discovery and Precision Medicine: Nvidia GTC and Precision Med TRI-CON
|
Mar 29, 2024 |
|
Optimizing Nanoparticles and Messenger RNAs with Multiple “Tails”
|
Mar 22, 2024 |
|
NanoString Finds a Buyer, Slide Tags Enter in Early Access as Curio Trekker, Cellares Unveils Cell Therapy Manufacturing Platform
|
Mar 15, 2024 |
|
International Women’s Day, Nanoparticles and Delivery, Novo Nordisk’s Expansion, and Organoids for Congenital Conditions
|
Mar 08, 2024 |
|
Moderna Gets Back to Its Roots, Form Bio and Ginkgo Bioworks Team Up, and Under-the-Radar Rare Autoimmune Diseases
|
Mar 01, 2024 |
|
Prime Editing for Isogenic iPSCs, PRINT, Universal In Vivo CAR T Editing, Biogen Q4 Results Disappoint; Andrea Choe
|
Feb 23, 2024 |
|
CRISPRed Pigs, Exscientia Fires CEO, & AGBT Roundup; Christian Henry
|
Feb 16, 2024 |
|
Intellia and Ultragenyx’s Clinical Updates, Novo Holdings’ Catalent Acquisition, and NanoString Bankruptcy; Simon Barnett
|
Feb 09, 2024 |
|
Genome Interpretation, Nanoparticles, Gene Therapy, 2024 IPOs; Nautilus Biotechnology
|
Feb 02, 2024 |
|
Restoring Hearing Loss, CAR T Manufacturing, DNA-Based Medicines, Nvidia and Recursion; Eric Topol
|
Jan 26, 2024 |
|
Alzheimer’s Disease, Monkey Cloning, Cytokinetics Stock; Jen Nwankwo
|
Jan 18, 2024 |
|
J.P. Morgan 2024: Illumina, 10x, Danaher, AI; Liberate Bio
|
Jan 11, 2024 |
|
Novartis and Voyager, JPM Ahead, Epigenetic Engineering; Alex Aravanis
|
Jan 05, 2024 |
|
Launch of Tome Biosciences, AI scientist, mRNA vaccines
|
Dec 21, 2023 |
|
Autism, AI and Epigenetics; Nevan Krogan
|
Dec 08, 2023 |